Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Target at $82.69

Shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) have been assigned a consensus rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […]

Related Keywords

United States ,Davidd Davidar ,Jamesr Tobin ,Piper Sandler ,Morgan Stanley ,Globus Medical Inc ,Stifel Financial Corp ,Credit Suisse Group ,Northwestern Mutual Investment Management Company ,Avantax Advisory Services Inc ,Canaccord Genuity Group ,Globus Medical Company Profile Get Rating ,Rothschild Investment Corp ,Globus Medical ,Get Rating ,Marketbeat Ratings ,Suisse Group ,Genuity Group ,Director David ,Director James ,Advisory Services ,Mutual Investment Management Company ,Financial Corp ,Investment Corp ,Medical Company Profile ,Nyse Gmed ,Sgmed ,Medical ,37957720 ,Ratings ,Consensus ,